ARMISTICE CAPITAL, LLC

Holdings History for Enlivex Therapeutics Ltd. - Ordinary Shares, par value NIS 0.40 per share (ENLV)

Symbol: ENLV on Nasdaq
Investment type: Equity - Shares of Stock
Class: Ordinary Shares, par value NIS 0.40 per share
Latest Disclosed Ownership: 2.21M shares
Security Ownership: 9.75%

Shares, Excluding Options vs Price

Value, Excluding Options

Armistice Capital, LLC ownership in Enlivex Therapeutics Ltd. Ordinary Shares, par value NIS 0.40 per share (ENLV)

2025-02-14 - Armistice Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.21M shares of Enlivex Therapeutics Ltd. Ordinary Shares, par value NIS 0.40 per share (ENLV). This represents 9.75% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Armistice Capital, LLC	9.75%		$2.65M	2.21M			$1.20	13G/A	12/31/2024	14 Feb 2025 17:43:19

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.06%	+0%	$2.58M	2.21M	+69,000	+3.23%	$1.17	Q4 2024
9/30/2024	0.09%	+0.02%	$3.59M	2.14M	+438,429	+25.8%	$1.68	Q3 2024
6/30/2024	0.06%	+0.06%	$2.41M	1.7M	+1,700,571	NEW	$1.42	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.